InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Kim Hyung Heon. Director active across 2 companies, notably NeuroBo Pharmaceuticals, Inc.. In total, 4 reports have been logged. History available since 11 August 2023. The latest transaction was filed on 1 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
4 of 4 declarations